| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adaptive Design Space as an Integrated Component of Quality by Design
|
Igne, Benoît
|
|
2012
|
|
3-4 |
p. 119-126
|
article
|
| 2 |
Adding a Factor in the Course of a Design Space Characterization
|
Schoen, Eric D.
|
|
2012
|
|
3-4 |
p. 163-173
|
article
|
| 3 |
Best Practices for Drug Substance Stress and Stability Studies During Early-Stage Development Part I—Conducting Drug Substance Solid Stress to Support Phase Ia Clinical Trials
|
Li, Q. Chan
|
|
2012
|
|
3-4 |
p. 214-224
|
article
|
| 4 |
Development of a Statistical Tolerance-Based Fluid Bed Drying Design Space
|
Zacour, Brian M.
|
|
2012
|
|
3-4 |
p. 151-162
|
article
|
| 5 |
DOE-Based CFD Optimization of Pharmaceutical Mixing Processes
|
Hörmann, Thomas
|
|
2012
|
|
3-4 |
p. 181-194
|
article
|
| 6 |
HPLC–MSn Analysis of Organic Acids and Glycosides in Qi-gui-yin Granules
|
Liu, Yonggang
|
|
2012
|
|
3-4 |
p. 174-180
|
article
|
| 7 |
Hybrid Controls Combining First-Principle Calculations with Empirical Modeling for Fully Automated Fluid Bed Processing
|
Zacour, Brian M.
|
|
2012
|
|
3-4 |
p. 140-150
|
article
|
| 8 |
Pharmaceutical Engineering Strategy for Quality Informatics on the IDEF0 Business Process Model
|
Kawai, Hirofumi
|
|
2012
|
|
3-4 |
p. 195-204
|
article
|
| 9 |
Real-time Exceptional Events Management for a Partial Continuous Dry Granulation Line
|
Hamdan, Intan Munirah
|
|
2012
|
|
3-4 |
p. 95-118
|
article
|
| 10 |
The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies
|
Colgan, Stephen T.
|
|
2012
|
|
3-4 |
p. 205-213
|
article
|
| 11 |
The Role of Pre-IPO Financial Indicators and Intermediaries in Aftermarket Performance and Survival in the US Biopharmaceutical Market
|
Williams, David R.
|
|
2012
|
|
3-4 |
p. 127-139
|
article
|
Journal description